메뉴 건너뛰기




Volumn 9, Issue 5, 2017, Pages 435-450

The ongoing evolution of antibody-based treatments for Ebola virus infection

Author keywords

clinical trials; convalescent plasma; Ebola virus; monoclonal antibodies; outbreak; pan ebolavirus; pan filovirus; therapeutics

Indexed keywords

6D6; FVM 09; MB 003; MIL 77E; MONOCLONAL ANTIBODY; MR 72; UNCLASSIFIED DRUG; VIRUS ANTIBODY; ZMAB; ZMAPP;

EID: 85016758672     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt-2017-0010     Document Type: Article
Times cited : (18)

References (65)
  • 1
    • 78449275458 scopus 로고    scopus 로고
    • Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations
    • Kuhn JH, Becker S, Ebihara H, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 155(12), 2083-2103 (2010
    • (2010) Arch. Virol , vol.155 , Issue.12 , pp. 2083-2103
    • Kuhn, J.H.1    Becker, S.2    Ebihara, H.3
  • 2
    • 34249289035 scopus 로고    scopus 로고
    • Filovirus replication and transcription
    • Mühlberger E. Filovirus replication and transcription. Future Virol. 2(2), 205-215 (2007
    • (2007) Future Virol , vol.2 , Issue.2 , pp. 205-215
    • Mühlberger, E.1
  • 3
    • 84918791874 scopus 로고    scopus 로고
    • Ebola virus outbreak 2014: Clinical review for emergency physicians
    • Meyers L, Frawley T, Goss S, Kang C. Ebola virus outbreak 2014: clinical review for emergency physicians. Ann. Emerg. Med. 65(1), 101-108 (2015
    • (2015) Ann. Emerg. Med , vol.65 , Issue.1 , pp. 101-108
    • Meyers, L.1    Frawley, T.2    Goss, S.3    Kang, C.4
  • 4
    • 84949460157 scopus 로고    scopus 로고
    • Molecular evidence of sexual transmission of Ebola virus
    • Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N. Engl. J. Med. 373(25), 2448-2454 (2015
    • (2015) N. Engl. J. Med , vol.373 , Issue.25 , pp. 2448-2454
    • Mate, S.E.1    Kugelman, J.R.2    Nyenswah, T.G.3
  • 7
    • 0032993303 scopus 로고    scopus 로고
    • Clinical, virologic, and immunologic follow-up of convalescent ebola hemorrhagic fever patients and their household contacts, kikwit, democratic republic of the congo commission de lutte contre les epidémies à kikwit
    • Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J. Infect. Dis. 179(Suppl. 1), S28-S35 (1999
    • (1999) J. Infect. Dis , vol.179 , pp. S28-S35
    • Rowe, A.K.1    Bertolli, J.2    Khan, A.S.3
  • 8
    • 84974717508 scopus 로고    scopus 로고
    • Filoviridae: Marburg and ebola viruses
    • Fields Virology. Knipe DM, Howley PM, Cohen JI, G DE, Lamb RA, Martin MA, Racaniello VR RB (Eds Williams & Wilkins, PA, USA
    • Feldmann H, Sanchez A, Geisbert TW. Filoviridae: Marburg and Ebola viruses. In: Fields Virology. Knipe DM, Howley PM, Cohen JI, G DE, Lamb RA, Martin MA, Racaniello VR RB (Eds). Lippincott Williams & Wilkins, PA, USA, 1410-1448 (2013
    • (2013) Lippincott , pp. 1410-1448
    • Feldmann, H.1    Sanchez, A.2    Geisbert, T.W.3
  • 9
    • 0017772897 scopus 로고
    • Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire
    • Johnson KM, Lange JV, Webb PA, Murphy FA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1(8011), 569-571 (1977
    • (1977) Lancet , vol.1 , Issue.8011 , pp. 569-571
    • Johnson, K.M.1    Lange, J.V.2    Webb, P.A.3    Murphy, F.A.4
  • 10
    • 0033036025 scopus 로고    scopus 로고
    • Ebola outbreak in Kikwit Democratic Republic of the Congo: Discovery and control measures
    • Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J. Infect. Dis. 179(Suppl. 1), S259-S262 (1999
    • (1999) J. Infect. Dis , vol.179 , pp. S259-S262
    • Muyembe-Tamfum, J.J.1    Kipasa, M.2    Kiyungu, C.3    Colebunders, R.4
  • 12
    • 84964363505 scopus 로고    scopus 로고
    • WHO 2016
    • WHO. Ebola Situation Report - 16 March 2016 (2016). http://apps.who.int/Ebola/current-situation/Ebola-situation-report-9-december-2015
    • (2016) Ebola Situation Report - 16 March
  • 13
    • 0033062193 scopus 로고    scopus 로고
    • Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients
    • International Scientific and Technical Committee
    • Mupapa K, Massamba M, Kibadi K, et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J. Infect. Dis. 179(Suppl. 1), S18-S23 (1999
    • (1999) J. Infect. Dis , vol.179 , pp. S18-S23
    • Mupapa, K.1    Massamba, M.2    Kibadi, K.3
  • 14
    • 84960470974 scopus 로고    scopus 로고
    • Progression of Ebola therapeutics during the 2014-2015 outbreak
    • Mendoza EJ, Qiu X, Kobinger GP. Progression of Ebola therapeutics during the 2014-2015 outbreak. Trends Mol. Med. 22(2), 164-173 (2016
    • (2016) Trends Mol. Med , vol.22 , Issue.2 , pp. 164-173
    • Mendoza, E.J.1    Qiu, X.2    Kobinger, G.P.3
  • 15
    • 34547937985 scopus 로고
    • The clinical uses of human serums preserved by the lyophile process
    • McGuinness AC, Stokes J, Mudd S. The clinical uses of human serums preserved by the lyophile process. J. Clin. Invest. 16(2), 185-196 (1937
    • (1937) J. Clin. Invest , vol.16 , Issue.2 , pp. 185-196
    • McGuinness, A.C.1    Stokes, J.2    Mudd, S.3
  • 16
    • 34249045924 scopus 로고
    • Value of convalescent blood and serum in treatment of influenzal pneumonia
    • Stoll HF. Value of convalescent blood and serum in treatment of influenzal pneumonia. JAMA 73(7), 478 (1919
    • (1919) JAMA , vol.73 , Issue.7 , pp. 478
    • Stoll, H.F.1
  • 17
    • 0036720105 scopus 로고    scopus 로고
    • A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies
    • Berger M. A history of immune globulin therapy, from the Harvard crash program to monoclonal antibodies. Curr. Allergy Asthma Rep. 2(5), 368-378 (2002
    • (2002) Curr. Allergy Asthma Rep , vol.2 , Issue.5 , pp. 368-378
    • Berger, M.1
  • 18
    • 84922676086 scopus 로고
    • Treatment of typhoid fever with convalescent whole blood
    • Dewar HA. Treatment of typhoid fever with convalescent whole blood. J. R. Army Med. Corps 86, 249-253 (1946
    • (1946) J. R. Army Med. Corps , vol.86 , pp. 249-253
    • Dewar, H.A.1
  • 20
    • 82555170327 scopus 로고    scopus 로고
    • From whole blood to component therapy: The economic, supply/demand need for implementation of component therapy in sub-Saharan Africa
    • Erhabor O, Adias TC. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa. Transfus. Clin. Biol. 18(5-6), 516-526 (2011
    • (2011) Transfus. Clin. Biol , vol.18 , Issue.5-6 , pp. 516-526
    • Erhabor, O.1    Adias, T.C.2
  • 21
    • 84943182977 scopus 로고    scopus 로고
    • Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid
    • Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, et al. Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir. Med. 3(7), 554-562 (2015
    • (2015) Spain. Lancet Respir. Med , vol.3 , Issue.7 , pp. 554-562
    • Mora-Rillo, M.1    Arsuaga, M.2    Ramírez-Olivencia, G.3
  • 22
    • 84959017828 scopus 로고    scopus 로고
    • Clinical management of Ebola virus disease in the United States and Europe
    • Uyeki TM, Mehta AK, Davey RT, et al. Clinical management of Ebola virus disease in the United States and Europe. N. Engl. J. Med. 374(7), 636-646 (2016
    • (2016) N. Engl. J. Med , vol.374 , Issue.7 , pp. 636-646
    • Uyeki, T.M.1    Mehta, A.K.2    Davey, R.T.3
  • 24
    • 84954349613 scopus 로고    scopus 로고
    • The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: A perspective from the field
    • Van Griensven J, De Weiggheleire A, Delamou A, et al. The use of Ebola convalescent plasma to treat Ebola virus disease in resource-constrained settings: a perspective from the field. Clin. Infect. Dis. 52(1), 69-74 (2015
    • (2015) Clin. Infect. Dis , vol.52 , Issue.1 , pp. 69-74
    • Van Griensven, J.1    De Weiggheleire, A.2    Delamou, A.3
  • 26
    • 84954049384 scopus 로고    scopus 로고
    • Evaluation of convalescent plasma for Ebola virus disease in Guinea
    • Van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N. Engl. J. Med. 374(1), 33-42 (2016
    • (2016) N. Engl. J. Med , vol.374 , Issue.1 , pp. 33-42
    • Van Griensven, J.1    Edwards, T.2    De Lamballerie, X.3
  • 27
    • 84930246161 scopus 로고    scopus 로고
    • Backs against the wall: Novel and existing strategies used during the 2014-2015 Ebola virus outbreak
    • Wong G, Kobinger GP. Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak. Clin. Microbiol. Rev. 28(3), 593-601 (2015
    • (2015) Clin. Microbiol. Rev , vol.28 , Issue.3 , pp. 593-601
    • Wong, G.1    Kobinger, G.P.2
  • 28
    • 85002487975 scopus 로고    scopus 로고
    • Ebola-Tx Consortium Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies
    • Van Griensven J, Edwards T, Baize S, Ebola-Tx Consortium. Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies. N. Engl. J. Med. 375(23), 2307-2309 (2016
    • (2016) N. Engl. J. Med , vol.375 , Issue.23 , pp. 2307-2309
    • Van Griensven, J.1    Edwards, T.2    Baize, S.3
  • 29
    • 79952943828 scopus 로고    scopus 로고
    • Fundamentals of vaccine immunology
    • Clem AS. Fundamentals of vaccine immunology. J. Glob. Infect. Dis. 3(1), 73-78 (2011
    • (2011) J. Glob. Infect. Dis , vol.3 , Issue.1 , pp. 73-78
    • Clem, A.S.1
  • 30
    • 84975516479 scopus 로고    scopus 로고
    • Ebola-Tx Consortiumi Convalescent plasma for Ebola virus disease
    • Van Griensven J, Edwards T, Gallian P, Ebola-Tx Consortium. Convalescent plasma for Ebola virus disease. N. Engl. J. Med. 374(25), 2500 (2016
    • (2016) N. Engl. J. Med , vol.374 , Issue.25 , pp. 2500
    • Van Griensven, J.1    Edwards, T.2    Gallian, P.3
  • 32
    • 84859462127 scopus 로고    scopus 로고
    • Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
    • Dye JM, Herbert AS, Kuehne AI, et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc. Natl Acad. Sci. USA 109(13), 5034-5039 (2012
    • (2012) Proc. Natl Acad. Sci. USA , vol.109 , Issue.13 , pp. 5034-5039
    • Dye, J.M.1    Herbert, A.S.2    Kuehne, A.I.3
  • 33
    • 84922806645 scopus 로고    scopus 로고
    • Molecular characterization of the monoclonal antibodies composing ZMAb: A protective cocktail against Ebola virus
    • Audet J, Wong G, Wang H, et al. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus. Sci. Rep. 4, 6881 (2014
    • (2014) Sci. Rep , vol.4 , pp. 6881
    • Audet, J.1    Wong, G.2    Wang, H.3
  • 34
    • 84944511031 scopus 로고    scopus 로고
    • Filovirus pathogenesis and immune evasion: Insights from Ebola virus and Marburg virus
    • Messaoudi I, Amarasinghe GK, Basler CF. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 13(11), 663-676 (2015
    • (2015) Nat. Rev. Microbiol , vol.13 , Issue.11 , pp. 663-676
    • Messaoudi, I.1    Amarasinghe, G.K.2    Basler, C.F.3
  • 35
    • 84862525229 scopus 로고    scopus 로고
    • Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies
    • 138ra81
    • Qiu X, Audet J, Wong G, et al. Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci. Transl. Med. 4(138), 138ra81 (2012
    • (2012) Sci. Transl. Med , vol.4 , Issue.138
    • Qiu, X.1    Audet, J.2    Wong, G.3
  • 36
    • 84945217199 scopus 로고    scopus 로고
    • Mechanism of binding to Ebola virus glycoprotein by the ZMapp ZMAb and MB-003 cocktail antibodies
    • Davidson E, Bryan C, Fong RH, et al. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89(21), 10982-10992 (2015
    • (2015) J. Virol , vol.89 , Issue.21 , pp. 10982-10992
    • Davidson, E.1    Bryan, C.2    Fong, R.H.3
  • 37
    • 84886410412 scopus 로고    scopus 로고
    • MAbs and Ad-vectored IFN-A therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms
    • 207ra143
    • Qiu X, Wong G, Fernando L, et al. mAbs and Ad-vectored IFN-A therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci. Transl. Med. 5(207), 207ra143 (2013
    • (2013) Sci. Transl. Med , vol.5 , Issue.207
    • Qiu, X.1    Wong, G.2    Fernando, L.3
  • 38
    • 84868149422 scopus 로고    scopus 로고
    • Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
    • Olinger GG, Pettitt J, Kim D, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc. Natl Acad. Sci. USA 109(44), 18030-18035 (2012
    • (2012) Proc. Natl Acad. Sci. USA , vol.109 , Issue.44 , pp. 18030-18035
    • Olinger, G.G.1    Pettitt, J.2    Kim, D.3
  • 39
    • 84945217199 scopus 로고    scopus 로고
    • Mechanism of binding to Ebola virus glycoprotein by the ZMapp ZMAb and MB-003 cocktail antibodies
    • Davidson E, Bryan C, Fong RH, et al. Mechanism of binding to Ebola virus glycoprotein by the ZMapp, ZMAb, and MB-003 cocktail antibodies. J. Virol. 89 (21), 10982-10992 (2015
    • (2015) J. Virol , vol.89 , Issue.21 , pp. 10982-10992
    • Davidson, E.1    Bryan, C.2    Fong, R.H.3
  • 40
    • 84883864987 scopus 로고    scopus 로고
    • Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB- 003 monoclonal antibody cocktail
    • 199ra113
    • Pettitt J, Zeitlin L, Kim DH, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB- 003 monoclonal antibody cocktail. Sci. Transl. Med. 5(199), 199ra113 (2013
    • (2013) Sci. Transl. Med , vol.5 , Issue.199
    • Pettitt, J.1    Zeitlin, L.2    Kim, D.H.3
  • 41
    • 84907263545 scopus 로고    scopus 로고
    • Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
    • Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514(7520), 47-53 (2014
    • (2014) Nature , vol.514 , Issue.7520 , pp. 47-53
    • Qiu, X.1    Wong, G.2    Audet, J.3
  • 44
    • 84912539210 scopus 로고    scopus 로고
    • Clinical care of two patients with Ebola virus disease in the United States
    • Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N. Engl. J. Med. 371(25), 2402-2409 (2014
    • (2014) N. Engl. J. Med , vol.371 , Issue.25 , pp. 2402-2409
    • Lyon, G.M.1    Mehta, A.K.2    Varkey, J.B.3
  • 45
    • 84940467204 scopus 로고    scopus 로고
    • Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: A case report
    • Schibler M, Vetter P, Cherpillod P, et al. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report. Lancet Infect. Dis. 3099(15), 1-7 (2015
    • (2015) Lancet Infect. Dis , vol.3099 , Issue.15 , pp. 1-7
    • Schibler, M.1    Vetter, P.2    Cherpillod, P.3
  • 46
    • 84948807329 scopus 로고    scopus 로고
    • Ebola viral load at diagnosis associates with patient outcome and outbreak evolution
    • De La Vega MA, Caleo G, Audet J, et al. Ebola viral load at diagnosis associates with patient outcome and outbreak evolution. J. Clin. Invest. 125(12), 4421-4428 (2015
    • (2015) J. Clin. Invest , vol.125 , Issue.12 , pp. 4421-4428
    • De La Vega, M.A.1    Caleo, G.2    Audet, J.3
  • 47
    • 84991259720 scopus 로고    scopus 로고
    • Multi-national prevail II study team a randomized, controlled trial of zmapp for ebola virus infection
    • PREVAIL II Writing Group
    • PREVAIL II Writing Group, Multi-National PREVAIL II Study Team. A randomized, controlled trial of ZMapp for Ebola virus infection. N. Engl. J. Med. 375(15), 1448-1456 (2016
    • (2016) N. Engl. J. Med , vol.375 , Issue.15 , pp. 1448-1456
  • 48
    • 8344236780 scopus 로고    scopus 로고
    • Plant cell cultures for the production of recombinant proteins
    • Hellwig S, Drossard J, Twyman RM, Fischer R. Plant cell cultures for the production of recombinant proteins. Nat. Biotechnol. 22(11), 1415-1422 (2004
    • (2004) Nat. Biotechnol , vol.22 , Issue.11 , pp. 1415-1422
    • Hellwig, S.1    Drossard, J.2    Twyman, R.M.3    Fischer, R.4
  • 49
    • 84908521422 scopus 로고    scopus 로고
    • WHO gives go ahead for experimental treatments to be used in Ebola outbreak
    • Sayburn A. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. BMJ 349, g5161 (2014
    • (2014) BMJ , vol.349 , pp. g5161
    • Sayburn, A.1
  • 50
    • 84923108405 scopus 로고    scopus 로고
    • Ebola drug trials lurch ahead
    • Kupferschmidt K, Cohen J. Ebola drug trials lurch ahead. Science 347(6223), 701-702 (2015
    • (2015) Science , vol.347 , Issue.6223 , pp. 701-702
    • Kupferschmidt, K.1    Cohen, J.2
  • 51
    • 84925581190 scopus 로고    scopus 로고
    • As Ebola epidemic begins to slow, trials of drugs and vaccines speed up
    • Kuehn BM. As Ebola epidemic begins to slow, trials of drugs and vaccines speed up. JAMA 313(10), 1000-1001 (2015
    • (2015) JAMA , vol.313 , Issue.10 , pp. 1000-1001
    • Kuehn, B.M.1
  • 52
    • 85006197840 scopus 로고    scopus 로고
    • Anti-Ebola therapies based on monoclonal antibodies: Current state and challenges ahead
    • González-González E, Alvarez MM, Márquez-Ipiña AR, et al. Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead. Crit. Rev. Biotechnol. 37(1), 1-16 (2015
    • (2015) Crit. Rev. Biotechnol , vol.37 , Issue.1 , pp. 1-16
    • González-González, E.1    Alvarez, M.M.2    Márquez-Ipiña, A.R.3
  • 53
    • 84964425104 scopus 로고    scopus 로고
    • CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody
    • Pettit DK, Rogers RS, Arthur K, et al. CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody. MAbs 8(2), 347-357 (2016
    • (2016) MAbs , vol.8 , Issue.2 , pp. 347-357
    • Pettit, D.K.1    Rogers, R.S.2    Arthur, K.3
  • 54
    • 77953655955 scopus 로고    scopus 로고
    • Industrialization of mAb production technology: The bioprocessing industry at a crossroads
    • Kelley B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. MAbs 1(5), 443-452 (2009
    • (2009) MAbs , vol.1 , Issue.5 , pp. 443-452
    • Kelley, B.1
  • 55
    • 84960417838 scopus 로고    scopus 로고
    • Two-mAb cocktail protects macaques against the Makona variant of Ebola virus
    • 329ra33
    • Qiu X, Audet J, Lv M, et al. Two-mAb cocktail protects macaques against the Makona variant of Ebola virus. Sci. Transl. Med. 8(329), 329ra33 (2016
    • (2016) Sci. Transl. Med , vol.8 , Issue.329
    • Qiu, X.1    Audet, J.2    Lv, M.3
  • 56
    • 84904596446 scopus 로고    scopus 로고
    • Specific polyclonal F(ab?)2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice
    • Herbreteau CH, Jacquot F, Rith S, et al. Specific polyclonal F(ab?)2 neutralize a large panel of highly pathogenic avian influenza A viruses (H5N1) and control infection in mice. Immunotherapy 6(6), 699-708 (2014). www.futuremedicine. com/doi/10.2217/imt.14.40
    • (2014) Immunotherapy , vol.6 , Issue.6 , pp. 699-708
    • Herbreteau, C.H.1    Jacquot, F.2    Rith, S.3
  • 57
    • 84923254084 scopus 로고    scopus 로고
    • Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab?)2 fragments against avian influenza A (H5N1) in healthy volunteers: A single-centre, randomised, double-blind, placebo-controlled, Phase 1 study
    • Bal C, Herbreteau CH, Buchy P, et al. Safety, potential efficacy, and pharmacokinetics of specific polyclonal immunoglobulin F(ab?)2 fragments against avian influenza A (H5N1) in healthy volunteers: a single-centre, randomised, double-blind, placebo-controlled, Phase 1 study. Lancet Infect. Dis. 15(3), 285-292 (2015). http://linkinghub. elsevier.com/retrieve/pii/S1473309914710722
    • (2015) Lancet Infect. Dis , vol.15 , Issue.3 , pp. 285-292
    • Bal, C.1    Herbreteau, C.H.2    Buchy, P.3
  • 58
    • 84897432390 scopus 로고    scopus 로고
    • Triple immunoglobulin gene knockout transchromosomic cattle: Bovine lambda cluster deletion and its effect on fully human polyclonal antibody production
    • Matsushita H, Sano A, Wu H, et al. Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production. PLoS ONE 9(3), e90383 (2014
    • (2014) PLoS ONE , vol.9 , Issue.3 , pp. e90383
    • Matsushita, H.1    Sano, A.2    Wu, H.3
  • 59
    • 84942826507 scopus 로고    scopus 로고
    • Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail
    • Kugelman JR, Kugelman-Tonos J, Ladner JT, et al. Emergence of Ebola virus escape variants in infected nonhuman primates treated with the MB-003 antibody cocktail. Cell Rep. 12(12), 2111-2120 (2015
    • (2015) Cell Rep , vol.12 , Issue.12 , pp. 2111-2120
    • Kugelman, J.R.1    Kugelman-Tonos, J.2    Ladner, J.T.3
  • 60
    • 84990963254 scopus 로고    scopus 로고
    • Preliminary evaluation of the effect of investigational Ebola virus disease treatments on viral genome sequences
    • Whitmer SLM, Albariño C, Shepard SS, et al. Preliminary evaluation of the effect of investigational Ebola virus disease treatments on viral genome sequences. J. Infect. Dis. 214(Suppl. 3), S333-S341 (2016
    • (2016) J. Infect. Dis , vol.214 , pp. S333-S341
    • Whitmer, S.L.M.1    Albariño, C.2    Shepard, S.S.3
  • 61
    • 84958078190 scopus 로고    scopus 로고
    • Discovery of an antibody for pan-Ebolavirus therapy
    • Furuyama W, Marzi A, Nanbo A, et al. Discovery of an antibody for pan-Ebolavirus therapy. Sci. Rep. 6, 20514 (2016
    • (2016) Sci. Rep , vol.6 , pp. 20514
    • Furuyama, W.1    Marzi, A.2    Nanbo, A.3
  • 62
    • 84953862148 scopus 로고    scopus 로고
    • Pan-Ebolavirus and Pan-filovirus mouse monoclonal antibodies: Protection against Ebola and Sudan viruses
    • Holtsberg FW, Shulenin S, Vu H, et al. Pan-Ebolavirus and Pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses. J. Virol. 90(1), 266-278 (2016
    • (2016) J. Virol , vol.90 , Issue.1 , pp. 266-278
    • Holtsberg, F.W.1    Shulenin, S.2    Vu, H.3
  • 63
    • 84934981152 scopus 로고    scopus 로고
    • Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone
    • Park DJ, Dudas G, Wohl S, et al. Ebola virus epidemiology, transmission, and evolution during seven months in Sierra Leone. Cell 161(7), 1516-1526 (2015
    • (2015) Cell , vol.161 , Issue.7 , pp. 1516-1526
    • Park, D.J.1    Dudas, G.2    Wohl, S.3
  • 64
    • 84875648000 scopus 로고    scopus 로고
    • Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure
    • Kajihara M, Nakayama E, Marzi A, Igarashi M, Feldmann H, Takada A. Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure. J. Gen. Virol. 94(4), 876-883 (2013
    • (2013) J. Gen. Virol , vol.94 , Issue.4 , pp. 876-883
    • Kajihara, M.1    Nakayama, E.2    Marzi, A.3    Igarashi, M.4    Feldmann, H.5    Takada, A.6
  • 65
    • 84988696751 scopus 로고    scopus 로고
    • Trojan horse? Bispecific antibody strategy for broad protection against Ebolaviruses
    • Wec AZ, Nyakatura EK, Herbert AS, et al. A ?Trojan horse? bispecific antibody strategy for broad protection against Ebolaviruses. Science 354(6310), 350-354 (2016
    • (2016) Science , vol.354 , Issue.6310 , pp. 350-354
    • Wec, A.Z.1    Nyakatura, E.K.2    Herbert, A.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.